Format

Send to

Choose Destination
Future Microbiol. 2016;11(1):103-17. doi: 10.2217/fmb.15.111. Epub 2015 Sep 15.

T2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasis.

Author information

1
T2 Biosystems, 101 Hartwell Ave, Lexington, MA 02421, USA.
2
University of Iowa College of Medicine & College of Public Health, Iowa City, IA, USA.
3
Geisinger Health Systems, Danville, PA, USA.

Abstract

Candidemia and other forms of invasive candidiasis pose a significant diagnostic challenge. In order to provide the best treatment, it is important to accurately detect the fungal infection and identify the species. Historically, diagnosis of Candida infections depended upon three classical laboratory approaches: microbiologic, immunologic, histopathologic; and now includes new methods such as radiographic techniques, molecular, proteomic and biochemical methods. The T2Candida Panel has introduced a new class of infectious disease diagnostics that can rapidly detect and identify the causative pathogen of sepsis directly from a patient blood sample in a culture-independent manner. This test enables detection of Candida directly from the patient sample, a significant advance for the rapid and accurate diagnosis of invasive candidiasis.

KEYWORDS:

Candida; T2Candida; T2MR; blood stream infection; diagnosis; magnetic resonance; nanotechnology; sepsis

PMID:
26371384
DOI:
10.2217/fmb.15.111
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center